FDA Drug Application (021759) for ELOXATIN by SANOFI AVENTIS US

Back to FDA Applications sponsored by SANOFI AVENTIS US

Application Number021759
Product Number001
FormINJECTABLE;IV (INFUSION)
Dosage50MG/10ML (5MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameELOXATIN
Active IngredientOXALIPLATIN

Active IngredientCount
List of drugs with Active Ingredient OXALIPLATIN2


Back to FDA Applications sponsored by SANOFI AVENTIS US